March 9, 2023
Pfizer’s oral COVID-19 medicine Paxlovid (nirmatrelvir/ritonavir) will join the NHI price list later this month with an NHI price of 99,027 yen per treatment course. A key health ministry panel approved the listing at its general meeting on March 8...read more